Subscribe Us

header ads

Recents

header ads

Veterinary Medicine Market Size, Growth, Demands Outlook and Forecasts to 2032

Precedence Research - February 01, 2023

According to the research report, the global veterinary medicine market size is expected to touch USD 93.67 Billion by 2032, from USD 45.71 Billion in 2022, growing with a significant CAGR of 7.43% from 2022 to 2032. 

Veterinary Medicine Market Size 2023 To 2032 - Precedence Statistics    

The veterinary medicine report offers a comprehensive study of the current state expected at the major drivers, market strategies, and key vendors’ growth. The report presents energetic visions to conclude and study the market size, market hopes, and competitive surroundings. The research also focuses on the important achievements of the market, research & development, and regional growth of the leading competitors operating in the market. The current trends of the global veterinary medicine in conjunction with the geographical landscape of this vertical have also been included in this report.

The report offers intricate dynamics about different aspects of the global veterinary medicine market, which aids companies operating in the market in making strategic development decisions. The study also elaborates on significant changes that are highly anticipated to configure growth of the global veterinary medicine during the forecast period. It also includes a key indicator assessment that highlights growth prospects of this market and estimates statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).

Sample Link @ https://www.precedenceresearch.com/sample/2584

 Report Scope of the Veterinary Medicine Market

Report CoverageDetails
Market Size in 2023USD 49.11 Billion
Market Size by 2032USD 93.67 Billion
Growth Rate from 2023 to 2032CAGR of 7.43%
Largest MarketNorth America
Base Year2022
Forecast Period2023 to 2032
Segments CoveredBy Animal Type, By Product, By Mode of Delivery and By End-User

This study covers a detailed segmentation of the global veterinary medicine market, along with key information and a competition outlook. The report mentions company profiles of players that are currently dominating the global veterinary medicine market, wherein various developments, expansions, and winning strategies practiced and implemented by leading players have been presented in detail.

Key Players

  • Ceva Sante Animale
  • Vetoquinol S.A.
  • Zoetis
  • Biogenesis Bago
  • Neogen Corp.
  • Hester Biosciences
  • Phibro Animal Health
  • Ceva Sante Animale
  • Vetoquinol S.A.
  • Dechra Pharmaceuticals PLC

Market Segmentation

 By Animal Type

  • Production
    • Poultry
    • Swine
    • Cattle
    • Sheep & Goats
    • Fish
  • Companion
    • Dogs
    • Cats
    • Horses
    • Others

By Product

  • Biologics
    • Vaccine
    • Live Attenuated Vaccines
    • DNA Vaccines
    • Recombinant Vaccines
    • Inactivated Vaccines
    • Others
  • Others
  • Pharmaceuticals
    • Parasiticides
    • Anti-infectives
    • Anti-inflammatory
    • Analgesics
    • Others
  • Medicated Feed Additives

By Mode of Delivery

  • Oral
    • Powder
    • Tablets
  • Parenteral
    • Suspension
    • Topical
    • Carrier
  • Other

By End-User

  • Reference Laboratories
  • Point-of-care Testing/In-house Testing
  • Veterinary Hospitals & Clinics
  • Others

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • The Middle East and Africa

Research Methodology

The research methodology adopted by analysts for compiling the global veterinary medicine report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.

During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.

For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global veterinary medicine market.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Veterinary Medicine Market 

5.1. COVID-19 Landscape: Veterinary Medicine Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Veterinary Medicine Market, By Animal Type

8.1. Veterinary Medicine Market, by Animal Type, 2023-2032

8.1.1. Production

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Companion

8.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Veterinary Medicine Market, By Product

9.1. Veterinary Medicine Market, by Product, 2023-2032

9.1.1. Biologics

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Others

9.1.2.1. Market Revenue and Forecast (2020-2032)

9.1.3. Pharmaceuticals

9.1.3.1. Market Revenue and Forecast (2020-2032)

9.1.4. Medicated Feed Additives

9.1.4.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Veterinary Medicine Market, By Mode of Delivery 

10.1. Veterinary Medicine Market, by Mode of Delivery, 2023-2032

10.1.1. Oral

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Parenteral

10.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global Veterinary Medicine Market, By End-User 

11.1. Veterinary Medicine Market, by End-User, 2023-2032

11.1.1. Reference Laboratories

11.1.1.1. Market Revenue and Forecast (2020-2032)

11.1.2. Point-of-care Testing/In-house Testing

11.1.2.1. Market Revenue and Forecast (2020-2032)

11.1.3. Veterinary Hospitals & Clinics

11.1.3.1. Market Revenue and Forecast (2020-2032)

11.1.4. Others

11.1.4.1. Market Revenue and Forecast (2020-2032)

Chapter 12. Global Veterinary Medicine Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Animal Type (2020-2032)

12.1.2. Market Revenue and Forecast, by Product (2020-2032)

12.1.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

12.1.4. Market Revenue and Forecast, by End-User (2020-2032)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Animal Type (2020-2032)

12.1.5.2. Market Revenue and Forecast, by Product (2020-2032)

12.1.5.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

12.1.5.4. Market Revenue and Forecast, by End-User (2020-2032)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Animal Type (2020-2032)

12.1.6.2. Market Revenue and Forecast, by Product (2020-2032)

12.1.6.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

12.1.6.4. Market Revenue and Forecast, by End-User (2020-2032)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Animal Type (2020-2032)

12.2.2. Market Revenue and Forecast, by Product (2020-2032)

12.2.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

12.2.4. Market Revenue and Forecast, by End-User (2020-2032)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Animal Type (2020-2032)

12.2.5.2. Market Revenue and Forecast, by Product (2020-2032)

12.2.5.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

12.2.5.4. Market Revenue and Forecast, by End-User (2020-2032)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Animal Type (2020-2032)

12.2.6.2. Market Revenue and Forecast, by Product (2020-2032)

12.2.6.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

12.2.6.4. Market Revenue and Forecast, by End-User (2020-2032)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Animal Type (2020-2032)

12.2.7.2. Market Revenue and Forecast, by Product (2020-2032)

12.2.7.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

12.2.7.4. Market Revenue and Forecast, by End-User (2020-2032)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Animal Type (2020-2032)

12.2.8.2. Market Revenue and Forecast, by Product (2020-2032)

12.2.8.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

12.2.8.4. Market Revenue and Forecast, by End-User (2020-2032)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Animal Type (2020-2032)

12.3.2. Market Revenue and Forecast, by Product (2020-2032)

12.3.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

12.3.4. Market Revenue and Forecast, by End-User (2020-2032)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Animal Type (2020-2032)

12.3.5.2. Market Revenue and Forecast, by Product (2020-2032)

12.3.5.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

12.3.5.4. Market Revenue and Forecast, by End-User (2020-2032)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Animal Type (2020-2032)

12.3.6.2. Market Revenue and Forecast, by Product (2020-2032)

12.3.6.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

12.3.6.4. Market Revenue and Forecast, by End-User (2020-2032)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Animal Type (2020-2032)

12.3.7.2. Market Revenue and Forecast, by Product (2020-2032)

12.3.7.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

12.3.7.4. Market Revenue and Forecast, by End-User (2020-2032)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Animal Type (2020-2032)

12.3.8.2. Market Revenue and Forecast, by Product (2020-2032)

12.3.8.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

12.3.8.4. Market Revenue and Forecast, by End-User (2020-2032)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Animal Type (2020-2032)

12.4.2. Market Revenue and Forecast, by Product (2020-2032)

12.4.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

12.4.4. Market Revenue and Forecast, by End-User (2020-2032)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Animal Type (2020-2032)

12.4.5.2. Market Revenue and Forecast, by Product (2020-2032)

12.4.5.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

12.4.5.4. Market Revenue and Forecast, by End-User (2020-2032)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Animal Type (2020-2032)

12.4.6.2. Market Revenue and Forecast, by Product (2020-2032)

12.4.6.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

12.4.6.4. Market Revenue and Forecast, by End-User (2020-2032)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Animal Type (2020-2032)

12.4.7.2. Market Revenue and Forecast, by Product (2020-2032)

12.4.7.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

12.4.7.4. Market Revenue and Forecast, by End-User (2020-2032)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Animal Type (2020-2032)

12.4.8.2. Market Revenue and Forecast, by Product (2020-2032)

12.4.8.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

12.4.8.4. Market Revenue and Forecast, by End-User (2020-2032)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Animal Type (2020-2032)

12.5.2. Market Revenue and Forecast, by Product (2020-2032)

12.5.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

12.5.4. Market Revenue and Forecast, by End-User (2020-2032)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Animal Type (2020-2032)

12.5.5.2. Market Revenue and Forecast, by Product (2020-2032)

12.5.5.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

12.5.5.4. Market Revenue and Forecast, by End-User (2020-2032)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Animal Type (2020-2032)

12.5.6.2. Market Revenue and Forecast, by Product (2020-2032)

12.5.6.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

12.5.6.4. Market Revenue and Forecast, by End-User (2020-2032)

Chapter 13. Company Profiles

13.1. Ceva Sante Animale

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Vetoquinol S.A.

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Zoetis

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Biogenesis Bago

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Neogen Corp.

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Hester Biosciences

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Phibro Animal Health

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Ceva Sante Animale

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Vetoquinol S.A.

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Dechra Pharmaceuticals PLC

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com

 

Tags:

Post a Comment

0 Comments